INS and diabetes mellitus: Both groups are given basic treatment[21–22]: on the basis of lifestyle interventions (diabetes diet, proper exercise), short-acting insulin subcutaneous injection is preferred to ensure that blood glucose can be controlled within the target range (FPG 6.1–7.8mmol/L, 2hPG 7.8–10 mmo/L).